IL138290A0 - Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage - Google Patents

Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage

Info

Publication number
IL138290A0
IL138290A0 IL13829099A IL13829099A IL138290A0 IL 138290 A0 IL138290 A0 IL 138290A0 IL 13829099 A IL13829099 A IL 13829099A IL 13829099 A IL13829099 A IL 13829099A IL 138290 A0 IL138290 A0 IL 138290A0
Authority
IL
Israel
Prior art keywords
desmethylselegiline
burns
selegiline
treating wounds
dermatological
Prior art date
Application number
IL13829099A
Other languages
English (en)
Original Assignee
Somerset Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somerset Pharmaceuticals Inc filed Critical Somerset Pharmaceuticals Inc
Publication of IL138290A0 publication Critical patent/IL138290A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
IL13829099A 1998-03-16 1999-03-03 Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage IL138290A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7804398P 1998-03-16 1998-03-16
PCT/US1999/004588 WO1999047133A1 (en) 1998-03-16 1999-03-03 Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage

Publications (1)

Publication Number Publication Date
IL138290A0 true IL138290A0 (en) 2001-10-31

Family

ID=22141568

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13829099A IL138290A0 (en) 1998-03-16 1999-03-03 Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
IL138290A IL138290A (en) 1998-03-16 2000-09-06 Use of selegiline or desmethylselegiline in the manufacture of medicaments for treating wounds, burns and dermatological damage

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL138290A IL138290A (en) 1998-03-16 2000-09-06 Use of selegiline or desmethylselegiline in the manufacture of medicaments for treating wounds, burns and dermatological damage

Country Status (13)

Country Link
US (3) US6461619B1 (xx)
EP (1) EP1063981B1 (xx)
CN (1) CN1154484C (xx)
AT (1) ATE222101T1 (xx)
AU (1) AU750909B2 (xx)
BR (1) BR9908713A (xx)
CA (1) CA2322878C (xx)
DE (1) DE69902520T2 (xx)
DK (1) DK1063981T3 (xx)
ES (1) ES2178405T3 (xx)
HK (1) HK1037980A1 (xx)
IL (2) IL138290A0 (xx)
WO (1) WO1999047133A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
BR9908713A (pt) 1998-03-16 2000-11-21 Somerset Pharmaceuticals Inc Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos
CA2420993A1 (en) * 2000-08-28 2002-03-14 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions
FR2813195B1 (fr) * 2000-08-29 2003-04-04 Serobiologiques Lab Sa Utilisation d'extraits de la plante cassia alata dans des produits de soin
EP1474158B1 (en) * 2001-12-18 2009-10-14 Brassica Foundation for Chemoprotection Research, Inc. Prevention and treatment of oxidative stress disorders by compounds which elevate intracellular levels of glutathione or phase ii detoxification enzymes
DE10229456A1 (de) * 2002-07-01 2004-02-05 Wank, Rudolf, Prof. Dr.med. Verwendung von Dopamin-Rezeptor-Agonisten zur Behandlung von Hautgeschwülsten und Warzen
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
US20090075860A1 (en) * 2005-04-28 2009-03-19 Japan Science And Technology Agency Transdermal absorption enhancer
ATE415153T1 (de) * 2005-06-06 2008-12-15 Nitto Denko Corp Pharmazeutische zusammensetzung zur perkutane absorption unter verwendung von einem metalchlorid, vorzugsweise natriumchlorid, zur vorbeugung von kohäsionsschwäche
US20090324693A1 (en) * 2008-06-30 2009-12-31 Kimberly-Clark Worldwide, Inc. Delivery Product for Topical Compositions
MX2013004214A (es) * 2010-10-15 2013-06-05 Procter & Gamble Uso de inhibidores de monoamina oxidasa para mejorar la biologia epitelial.
CA2821715A1 (en) * 2010-12-14 2012-06-21 University Of Rochester Chimeric fibronectin matrix mimetics and uses thereof
US9539201B2 (en) 2012-04-20 2017-01-10 KAT Transdermals LLC Selegiline transdermal system
IT201800006455A1 (it) * 2018-06-19 2019-12-19 Nuovo utilizzo degli inibitori della monoammino ossidasi B

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2029805T3 (es) 1986-04-16 1992-10-01 Asta Pharma Aktiengesellschaft Procedimiento para preparar un producto que contiene amantadina y selegilina en asociacion sinergica.
ATE76747T1 (de) 1986-06-10 1992-06-15 Chiesi Farma Spa Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
US4868218A (en) 1987-08-18 1989-09-19 Buyske Donald A Method of treating depression
US4861800A (en) 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
GB8807504D0 (en) 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
US4959205A (en) * 1989-03-23 1990-09-25 Collagen Corporation Composition and method for treatment of dermal inflammation
US5190763A (en) 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5192550A (en) 1990-05-07 1993-03-09 Alza Corporation Dosage form for treating central nervous system disorders
US5221536A (en) 1990-05-07 1993-06-22 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5128145A (en) 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
US5057321A (en) 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin
CA2039194C (en) 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5783606A (en) * 1995-02-10 1998-07-21 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
HU209605B (en) 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
US5266332A (en) 1991-12-06 1993-11-30 Alza Corporation Method for administering anti-Parkinson drug
EP0593807A1 (en) 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
US5242950A (en) 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5354885A (en) 1992-12-24 1994-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Process for preparing ethyl ester of L-DOPA
FR2713087B1 (fr) * 1993-11-30 1996-02-23 Saurat Jean Hilaire Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis.
FR2728790B1 (fr) * 1994-12-29 1997-01-24 Cird Galderma Composition modulant l'apoptose comprenant du methonial ou tout facteur influencant le taux intracellulaire de methonial
CN100360123C (zh) * 1995-01-13 2008-01-09 萨默塞特药品有限公司 应用去甲司来吉兰的方法和医药组合物
JP3258027B2 (ja) * 1996-03-15 2002-02-18 サマーセット・ファーマシューティカルズ・インコーポレイテッド セレジリン投与による末梢ニューロパシーの予防および治療方法
US6262111B1 (en) * 1997-05-21 2001-07-17 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
US20020006913A1 (en) * 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
BR9908713A (pt) * 1998-03-16 2000-11-21 Somerset Pharmaceuticals Inc Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos

Also Published As

Publication number Publication date
BR9908713A (pt) 2000-11-21
US20030021833A1 (en) 2003-01-30
US6709664B2 (en) 2004-03-23
ES2178405T3 (es) 2002-12-16
CA2322878C (en) 2008-05-06
CN1154484C (zh) 2004-06-23
AU2979199A (en) 1999-10-11
US6461619B1 (en) 2002-10-08
EP1063981B1 (en) 2002-08-14
DE69902520D1 (de) 2002-09-19
HK1037980A1 (en) 2002-03-01
DK1063981T3 (da) 2002-10-14
ATE222101T1 (de) 2002-08-15
CN1300209A (zh) 2001-06-20
EP1063981A1 (en) 2001-01-03
IL138290A (en) 2010-05-17
DE69902520T2 (de) 2003-04-10
WO1999047133A1 (en) 1999-09-23
US20040180009A1 (en) 2004-09-16
CA2322878A1 (en) 1999-09-23
AU750909B2 (en) 2002-08-01
US7147864B2 (en) 2006-12-12

Similar Documents

Publication Publication Date Title
MY119711A (en) Method of inhibiting photoaging of skin
EP0590076A4 (en) Production of human hemoglobin in transgenic pigs
EP0801946A3 (de) Verwendung von Salicin als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
IL138290A0 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
PT880350E (pt) Tratamento de esclerose multipla
DE69613840D1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
ATE186834T1 (de) Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut
DE69731477D1 (de) Mittel zur akne behandlung
RU94022017A (ru) Способ лечения акне или псевдофолликулита бороды, способ получения композиции, применение ингибитора фермента орнитиндекарбоксилазы для лечения акне или псевдофолликулита бороды
MY164077A (en) Compositions and uses of et743 for treating cancer
GEP20063828B (en) Methods for Treating or Preventing Skin Disorders Using CD2-Binding Agents
DE69426267T2 (de) Äusserlisches Hautbehandlungsmittel
DE69800859T2 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
ES2159983T3 (es) Composicion que contiene urea y sus utilizaciones en el ambito cosmetico y/o dermatologico.
ES2186914T3 (es) Utilizacion cosmetica, dermatologica y farmaceutica de un extracto de terminalia catappa.
DE69932922D1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
ES2187836T3 (es) Utilizacion de un extracto de terminalia catappa.
GB2347625A (en) Agent for treating allergic or hypersensivity condition
HUP9900007A2 (hu) Készítmény baromfialom kezelésére
PT1140001E (pt) Composicao para tratamento de queimaduras
HUP0101602A2 (hu) Termékenységet javító készítmény, és annak alkalmazása
DE69626691T2 (de) Komponente b als wundheilendes mittel
RU94039553A (ru) Средство для лечения хронического простатита
UA30421A (uk) Компрес для лікування запального процесу і болю